Citation Impact
Citing Papers
Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients
2018
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Human T H 9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity
2014
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
2014
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
BCL6 Controls Th9 Cell Development by Repressing Il9 Transcription
2014
Thymus‐derived regulatory T cells restrain pro‐inflammatory Th1 responses by downregulating CD 70 on dendritic cells
2015
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Cytokines in inflammatory bowel disease
2014 Standout
The development and in vivo function of T helper 9 cells
2015
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Fast, sensitive and accurate integration of single-cell data with Harmony
2019 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Single-cell sequencing of human white adipose tissue identifies new cell states in health and obesity
2021
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice
2015
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Immune mechanisms in medium and large-vessel vasculitis
2013
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
IL‐9 is a Th17‐derived cytokine that limits pathogenic activity in organ‐specific autoimmune disease
2011
Inducing and Administering Tregs to Treat Human Disease
2016
Delivery technologies for cancer immunotherapy
2019 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment
2017
Asthma
2017 Standout
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155
2016
Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis
2017
Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of Psoriasis
2013
Psoriasis
2015 Standout
Extracellular matrix structure
2015 Standout
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
2014
Immunopathology of multiple sclerosis
2015 Standout
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy
2015
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
2018
PD-1 marks dysfunctional regulatory T cells in malignant gliomas
2016
The immunology of asthma
2014
Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors
2015
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
2015
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
2021
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
2014
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
2017
CD226 opposes TIGIT to disrupt Tregs in melanoma
2018
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease
2011
Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells
2019 StandoutNobel
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
2016
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Unexpected Help: Follicular Regulatory T Cells in the Germinal Center
2018
Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase
2015
Defining trained immunity and its role in health and disease
2020 Standout
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
2014
Differentiation and Immune Regulation of IL-9−Producing CD4 + T Cells in Malignant Pleural Effusion
2012
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
CD28 co-stimulation is dispensable for the steady state homeostasis of intestinal regulatory T cells
2018
CCR8+FOXp3+Tregcells as master drivers of immune regulation
2017
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion
2023
Regulatory T Cells and Human Disease
2020 StandoutNobel
Coinhibitory Pathways in Immunotherapy for Cancer
2016
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
2016
Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells
2013
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
2015
Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice
2016
Echinococcosis: Advances in the 21st Century
2019 Standout
Molecular control of regulatory T cell development and function
2017 StandoutNobel
Th9 cells: differentiation and disease
2013
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Mitochondrial complex III is essential for suppressive function of regulatory T cells
2019 Nature
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Cell‐surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases
2013
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
2015
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Singular role for T-BET + CXCR3 + regulatory T cells in protection from autoimmune diabetes
2016
Spatial distribution and function of T follicular regulatory cells in human lymph nodes
2018
2017
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
2020
Bromodomain and Extra-Terminal Motif Inhibitors: a Review of Preclinical and Clinical Advances in Cancer Therapy
2019
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
2015
Mouse TIGIT inhibits NK ‐cell cytotoxicity upon interaction with PVR
2013
Works of Ester Lozano being referenced
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
2020
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
2014
Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis
2010
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling
2017
Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways
2009
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis
2012
TGF-β Induces IL-9 Production from Human Th17 Cells
2010
The CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in Humans
2013
The TIGIT/CD226 Axis Regulates Human T Cell Function
2012